13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001964437-25-000013
Total Value
$456.0M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 801,224 | $68.0M | 14.92% |
| 2 | AMYLYX PHARMACEUTICALS INC | AMLX | 4,604,878 | $62.6M | 13.72% |
| 3 | JAZZ PHARMACEUTICALS PLC | JAZZ | 300,610 | $39.6M | 8.69% |
| 4 | DYNE THERAPEUTICS INC | DYN | 2,674,469 | $33.8M | 7.42% |
| 5 | COGENT BIOSCIENCES INC | COGT | 2,025,041 | $29.1M | 6.38% |
| 6 | VAXCYTE INC | PCVX | 788,441 | $28.4M | 6.23% |
| 7 | CELCUITY INC | CELC | 473,828 | $23.4M | 5.13% |
| 8 | CG ONCOLOGY INC | CGON | 579,895 | $23.4M | 5.12% |
| 9 | DISC MEDICINE INC | IRON | 340,897 | $22.5M | 4.94% |
| 10 | PHARVARIS N V | PHVS | 886,332 | $22.1M | 4.85% |
| 11 | XENON PHARMACEUTICALS INC | XENE | 503,701 | $20.2M | 4.44% |
| 12 | CENTESSA PHARMACEUTICALS PLC | CNTA | 734,539 | $17.8M | 3.91% |
| 13 | MERUS N V | N5749R100 | 184,135 | $17.3M | 3.80% |
| 14 | LENZ THERAPEUTICS INC | LENZ | 368,176 | $17.1M | 3.76% |
| 15 | OCULAR THERAPEUTIX INC | OCUL | 1,151,686 | $13.5M | 2.95% |
| 16 | MONOPAR THERAPEUTICS INC | MNPR | 155,370 | $12.7M | 2.78% |
| 17 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 153,147 | $4.4M | 0.96% |